Search - tctmd.com

Displaying 1 - 20 of 457

Sort: Relevancy | Date

News Conference News EuroPCR 2025

Short DAPT All That’s Needed With Contemporary DES: HOST-IDEA at 3 Years

Yael L. Maxwell

June 02, 2025

News Conference News EuroPCR 2025

Short DAPT Safe in ACS With No Ischemic Penalty: 4D-ACS

L.A. McKeown

May 30, 2025

News Conference News EuroPCR 2025

FLAVOUR Confirms Long-term Noninferiority of FFR vs IVUS to Guide PCI

Yael L. Maxwell

May 30, 2025

News Conference News EuroPCR 2025

‘Quick and Sustained’ Bumps in HR and BP When Beta-blockers Stopped Post-MI

Michael O'Riordan

May 29, 2025

News Conference News EuroPCR 2025

Early Coronary Function Testing Improves Quality of Life in ANOCA

Yael L. Maxwell

May 28, 2025

News Conference News EuroPCR 2025

OCT-Guided PCI Bests Angiography in ACS Patients: OCCUPI

L.A. McKeown

May 28, 2025

News Daily News EuroPCR 2025

Underexpanded Acurate neo2 Valves Tied to Worse Outcomes: ACURATE IDE

Michael O'Riordan

May 28, 2025

News Conference News EuroPCR 2025

PREDICT Offers a Heads-up on the Need for CT in Suspected Small Aortic Annuli

L.A. McKeown

May 23, 2025

News Conference News EuroPCR 2025

Stroke Risk Higher With TAVI vs Surgery at 5 Years: UK TAVI

Michael O'Riordan

May 23, 2025

News Conference News EuroPCR 2025

Short DAPT in High-Bleeding-Risk Patients Reduces Recurrent Events: MASTER DAPT

Yael L. Maxwell

May 23, 2025

News Conference News EuroPCR 2025

Lower MACE Risk With FFR- vs Angio-Guided PCI in AS Patients: FAITAVI

L.A. McKeown

May 22, 2025

News Conference News EuroPCR 2025

Higher Mortality With TAVI Over Surgery in Bicuspid Aortic Stenosis

Michael O'Riordan

May 22, 2025

News Conference News EuroPCR 2025

IVL Effective in Severely Calcified Lesions, Especially in Women

Yael L. Maxwell

May 22, 2025

Presentation EuroPCR 2025

The EMPOWER CAD study: women with calcified coronary arteries treated with intravascular lithotripsy

Presenter: Margaret McEntegart

May 22, 2025

Presentation EuroPCR 2025

Surgical versus percutaneous treatment of bicuspid aortic stenosis: a propensity score analysis

Presenter: Pierre Deharo

May 22, 2025

Presentation EuroPCR 2025

One-year outcomes of LANDMARK

Presenter: Patrick W. Serruys

May 22, 2025

Presentation EuroPCR 2025

Final seven-year outcome of the COMPARE-ABSORB trial

Presenter: Pieter Smits

May 22, 2025

Presentation EuroPCR 2025

Complete or culprit-only revascularisation in STEMI: 10-year outcome of DANAMI-3-PRIMULTI

Presenter: Thomas Engstrøm

May 22, 2025

Presentation EuroPCR 2025

Angiography versus physiology-guided PCI in patients undergoing TAVI: the functional assessment in TAVI (FAITAVI) trial

Presenter: Flavio Ribichini

May 22, 2025

Presentation EuroPCR 2025

A randomised trial of coronary function testing-guided treatment versus standard care in ANOCA

Presenter: Tim Van De Hoef

May 22, 2025

Advertisement

Short DAPT All That’s Needed With Contemporary DES: HOST-IDEA at 3 Years

Short DAPT Safe in ACS With No Ischemic Penalty: 4D-ACS

FLAVOUR Confirms Long-term Noninferiority of FFR vs IVUS to Guide PCI

‘Quick and Sustained’ Bumps in HR and BP When Beta-blockers Stopped Post-MI

Early Coronary Function Testing Improves Quality of Life in ANOCA

OCT-Guided PCI Bests Angiography in ACS Patients: OCCUPI

Underexpanded Acurate neo2 Valves Tied to Worse Outcomes: ACURATE IDE

PREDICT Offers a Heads-up on the Need for CT in Suspected Small Aortic Annuli

Stroke Risk Higher With TAVI vs Surgery at 5 Years: UK TAVI

Short DAPT in High-Bleeding-Risk Patients Reduces Recurrent Events: MASTER DAPT

Lower MACE Risk With FFR- vs Angio-Guided PCI in AS Patients: FAITAVI

Higher Mortality With TAVI Over Surgery in Bicuspid Aortic Stenosis

IVL Effective in Severely Calcified Lesions, Especially in Women

The EMPOWER CAD study: women with calcified coronary arteries treated with intravascular lithotripsy

Surgical versus percutaneous treatment of bicuspid aortic stenosis: a propensity score analysis

One-year outcomes of LANDMARK

Final seven-year outcome of the COMPARE-ABSORB trial

Complete or culprit-only revascularisation in STEMI: 10-year outcome of DANAMI-3-PRIMULTI

Angiography versus physiology-guided PCI in patients undergoing TAVI: the functional assessment in TAVI (FAITAVI) trial

A randomised trial of coronary function testing-guided treatment versus standard care in ANOCA

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content